Out study showed that treatment with anti-IL-9Ab and anti-IL-17Ab exerted similar effects on suppressing plasma secretion and liver expression of TGF-β1, IL-6, TNF-α, IL-4 and IL-9 in mice with liver fibrosis. This evidence concerns the gene TGFB1 and Hepatic fibrosis.